NO813208L - Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater. - Google Patents

Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.

Info

Publication number
NO813208L
NO813208L NO813208A NO813208A NO813208L NO 813208 L NO813208 L NO 813208L NO 813208 A NO813208 A NO 813208A NO 813208 A NO813208 A NO 813208A NO 813208 L NO813208 L NO 813208L
Authority
NO
Norway
Prior art keywords
isotiazole
aryl
derivatives
preparing
procedure
Prior art date
Application number
NO813208A
Other languages
English (en)
Norwegian (no)
Inventor
James Richard Beck
Robert Peter Gajewski
Ronald Ervin Hacler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO813208L publication Critical patent/NO813208L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO813208A 1980-09-22 1981-09-21 Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater. NO813208L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/189,435 US4346094A (en) 1980-09-22 1980-09-22 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels

Publications (1)

Publication Number Publication Date
NO813208L true NO813208L (no) 1982-03-23

Family

ID=22697314

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813208A NO813208L (no) 1980-09-22 1981-09-21 Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.

Country Status (22)

Country Link
US (1) US4346094A (cs)
EP (1) EP0048615B1 (cs)
JP (1) JPS5785379A (cs)
KR (1) KR830007597A (cs)
AR (1) AR229103A1 (cs)
AT (1) ATE7657T1 (cs)
AU (1) AU7551681A (cs)
CS (1) CS228536B2 (cs)
DD (1) DD201790A5 (cs)
DE (1) DE3163900D1 (cs)
DK (1) DK417981A (cs)
ES (1) ES8301225A1 (cs)
FI (1) FI812940L (cs)
GB (1) GB2084573B (cs)
GR (1) GR75046B (cs)
IL (1) IL63890A0 (cs)
NO (1) NO813208L (cs)
PL (1) PL130497B1 (cs)
PT (1) PT73711B (cs)
RO (1) RO82216A (cs)
YU (1) YU227181A (cs)
ZA (1) ZA816549B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4428956A (en) 1980-12-29 1984-01-31 Merck & Co., Inc. 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4431652A (en) * 1980-12-29 1984-02-14 Merck & Co., Inc. 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis
US4539328A (en) * 1983-03-25 1985-09-03 Fmc Corporation Nematicidal isothiazole derivatives
US4620865A (en) * 1983-11-07 1986-11-04 Eli Lilly And Company Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
ZW21687A1 (en) * 1986-12-12 1988-07-20 Hoffmann La Roche Triazine derivatives
SG86971A1 (en) * 1990-11-30 2002-03-19 Teijin Ltd 2-arylthiazole derivatives and pharmaceutical composition thereof
US5294630A (en) * 1992-07-07 1994-03-15 Eli Lilly And Company Treatment of inflammatory bowel disease
US5436258A (en) * 1992-09-09 1995-07-25 Eli Lilly And Company Prevention of bone resorption
MY117352A (en) * 1995-10-31 2004-06-30 Ciba Sc Holding Ag Oximesulfonic acid esters and the use thereof as latent sulfonic acids.
ID21775A (id) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
EP1044002A4 (en) 1997-11-07 2003-05-02 Univ Johns Hopkins METHODS FOR THE TREATMENT OF HEART CONTRACTILITY
TW575792B (en) * 1998-08-19 2004-02-11 Ciba Sc Holding Ag New unsaturated oxime derivatives and the use thereof as latent acids
SG78412A1 (en) 1999-03-31 2001-02-20 Ciba Sc Holding Ag Oxime derivatives and the use thereof as latent acids
KR20040089607A (ko) 2002-02-06 2004-10-21 시바 스페셜티 케미칼스 홀딩 인크. 설포네이트 유도체 및 잠산으로서의 이의 용도
WO2006022374A1 (ja) * 2004-08-27 2006-03-02 Astellas Pharma Inc. 2-フェニルピリジン誘導体
US7612108B2 (en) * 2004-08-27 2009-11-03 Astellas Pharma Inc. 2-phenylthiophene derivative
ES2355068T3 (es) 2005-10-07 2011-03-22 Astellas Pharma Inc. Derivado del ácido triarilcarboxílico.
PT1992361E (pt) 2006-02-24 2012-07-10 Astellas Pharma Inc Medicamento ou agente preventivo contra úlceras digestivas
GB2450975B (en) 2007-07-12 2010-02-24 Ciba Holding Inc Yellow radiation curing inks
WO2009143020A1 (en) * 2008-05-22 2009-11-26 Bristol-Myers Squibb Company Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same
DK2404908T3 (da) 2009-02-27 2014-04-28 Teijin Pharma Ltd Fremgangsmåde til fremstilling af phenyl-substitueret heterocyclisk derivat gennem kobling under anvendelse af en overgangsmetalkatalysator
WO2010112408A1 (en) 2009-03-30 2010-10-07 Basf Se Uv-dose indicator films
CN103068807B (zh) 2010-08-27 2016-05-25 帝人制药株式会社 通过使用钯化合物的偶合法的苯基取代杂环衍生物的制备方法
CN103443072B (zh) 2011-01-28 2016-05-18 巴斯夫欧洲公司 包含肟磺酸酯作为热固化剂的可聚合组合物
SI2980085T1 (en) * 2013-03-29 2018-08-31 Teijin Pharma Limited Derivate pyrazole
US10487050B2 (en) 2014-08-29 2019-11-26 Basf Se Oxime sulfonate derivatives
BR112017023057B1 (pt) 2015-04-29 2023-03-28 Bsn Medical Gmbh Processo para preparação de no e processo cosmético
BR112017023170B1 (pt) 2015-04-29 2022-08-16 Bsn Medical Gmbh Dispositivo de banho medicinal e seu uso

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1178604A (en) * 1966-03-21 1970-01-21 American Cyanamid Co Novel Pyridinium Salts and Methods for Preparing Same
US3464999A (en) * 1967-07-27 1969-09-02 R & L Molecular Research Ltd Thiadiazolylisothiazoles
GB1180268A (en) * 1967-09-26 1970-02-04 Ici Ltd Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives
GB1192701A (en) * 1968-03-22 1970-05-20 Ici Ltd Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same
US3681498A (en) * 1970-10-19 1972-08-01 American Cyanamid Co Isothiazolyl pyridinium salts as hypoglycemic agents

Also Published As

Publication number Publication date
RO82216A (ro) 1983-07-07
PL130497B1 (en) 1984-08-31
PL233103A1 (cs) 1982-12-20
GB2084573A (en) 1982-04-15
EP0048615B1 (en) 1984-05-30
CS228536B2 (en) 1984-05-14
JPS5785379A (en) 1982-05-28
FI812940A7 (fi) 1982-03-23
IL63890A0 (en) 1981-12-31
FI812940L (fi) 1982-03-23
DE3163900D1 (en) 1984-07-05
PT73711B (en) 1982-12-20
AR229103A1 (es) 1983-06-15
KR830007597A (ko) 1983-11-04
ATE7657T1 (de) 1984-06-15
US4346094A (en) 1982-08-24
GB2084573B (en) 1984-09-12
ES505678A0 (es) 1982-12-01
DK417981A (da) 1982-03-23
RO82216B (ro) 1983-06-30
ZA816549B (en) 1983-04-27
ES8301225A1 (es) 1982-12-01
PT73711A (en) 1981-10-01
YU227181A (en) 1983-10-31
EP0048615A1 (en) 1982-03-31
AU7551681A (en) 1982-04-01
GR75046B (cs) 1984-07-12
DD201790A5 (de) 1983-08-10

Similar Documents

Publication Publication Date Title
NO813208L (no) Fremgangsmaate for fremstilling av 3-aryl-5-isotiazol-derivater.
ES507715A0 (es) Procedimiento para preparar derivados de 1-sulfo-2-oxoazetidina .
ES520638A0 (es) Procedimiento de preparar compuestos carbostirilicos.
ES507493A0 (es) Procedimiento de preparar compuestos benzoheterociclicos.
NO851921L (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifanycin-derivater.
ES507126A0 (es) Procedimiento para preparar derivados de piridona.
NO810610L (no) Fremgangsmaate for fremstilling av piperidinderivater
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
ES507545A0 (es) Procedimiento de preparar compuestos carbostirilicos.
NO851466L (no) Fremgangsmaate for fremstilling av 9a-aza-9a-homoery-tromycin-derivater.
NO813442L (no) Fremgangsmaate for fremstilling av 2-guanidin-4-heteroaryltiazolderivater
NO152894C (no) Fremgangsmaate ved fremstilling av ureapellets.
NO822410L (no) Fremgangsmaate ved fremstilling av benzothiazolsulfonamid-derivater.
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
ES506842A0 (es) Procedimiento para preparar derivados 3-aminopropoxifenili- cos.
NO820980L (no) Fremgangsmaate for fremstilling av imidazo-pyrimidin-derivater
NO812841L (no) Fremgangsmaate til fremstilling av florerte pentendiaminderivater
FI800943A7 (fi) Menetelmä bentsodiatsepiinijohdannaisten valmistamiseksi.
NO157143C (no) Fremgangsmaate for fremstilling av karbapen-2-em-derivater.
NO165107C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
FI810495A7 (fi) Fenoksiaminopropanolijohdannaisia.
FI811706A7 (fi) Substituoituja fenoksi-aminopropanoli- johdannaisia.
FI823910A7 (fi) Atsolyyli-penteeni- johdannaisia, menetelmiä näiden yhdisteiden valmistamiseksi sekä niitä sisältäviä bibiosidejä.
NO155732C (no) Fremgangsmaate for fremstilling av kijanimicin.
EP0066628A4 (en) Pyridine derivatives.